News & Insights
How Healthcare Organizations Can Evaluate an Approach to EMR Integration
In 2020, we kicked off a three-part blog series examining the challenges of EMR interrogation and the best time to interrogate EMRs for clinical...
Clinical Research News — There’s Got To Be A Better Way to Fight Cancer When Everything Else Is Falling Apart
COVID-19 has disrupted healthcare in myriad ways. It includes treatment options that may be part of clinical trials may be taken off the table.
Signify Research 2020 report explores how companies like Inteliquet are guiding the adoption of AI solutions for drug development and clinical trials
Inteliquet™, Inc. is featured as a leading company in AI in Drug Development & Clinical Trials – World – 2020, a comprehensive...
TrialSite News — What Can We Do About Clinical Trials As The Pandemic Continues to Get Worse?
Has anyone in your family had to cancel a doctor’s appointment or hospital visit in recent months? The answer is likely to be yes. Many medical...
MedCity News — Covid-19 is derailing cancer clinical trials. Is new technology required to get them back on track?
It is time to make it our collective mission to bring data automation to patient recruiting for clinical trials…
Managed Healthcare Executive — Improving Cancer Research Priorities in Light of COVID
Marie Lamont, president and COO, shares what took place in the drop of oncology-related activity and what can be done to improve the battle in cancer research in light of COVID.
Signify Research 2020 report explores how companies like Inteliquet are guiding the adoption of AI solutions for drug development and clinical trials
Inteliquet™, Inc. is featured as a leading company in AI in Drug Development & Clinical Trials – World – 2020, a comprehensive...
TrialSite News — What Can We Do About Clinical Trials As The Pandemic Continues to Get Worse?
Has anyone in your family had to cancel a doctor’s appointment or hospital visit in recent months? The answer is likely to be yes. Many medical...
MedCity News — Covid-19 is derailing cancer clinical trials. Is new technology required to get them back on track?
It is time to make it our collective mission to bring data automation to patient recruiting for clinical trials…
Managed Healthcare Executive — Improving Cancer Research Priorities in Light of COVID
Marie Lamont, president and COO, shares what took place in the drop of oncology-related activity and what can be done to improve the battle in cancer research in light of COVID.
TANDY TIPPS, PH.D. TO LEAD INTELIQUET™ HEALTHCARE SOLUTIONS AND FURTHER EXPAND CANCER CENTER RESEARCH CONSORTIUM
Seasoned Oncology Executive Brings Voice of Cancer Centers
Dave Hadley, PhD, Chosen For The 2020 Class Of “40 Under 40 in Cancer”
Inteliquet’s David Hadley, PhD, our Director of Data Science, was recognized as a member of the 2020 class of “40 Under 40 in Cancer.”
Outsourcing Pharma – Inteliquet: COVID-19 transforming oncology trial landscape
Outsourcing-Pharma spoke with Marie Lamont about Inteliquet, challenges impacting cancer research, and what the future might hold for the industry.
Interrogating EMRs for Clinical Trial Recruitment … When is the Best Time?
There are complexities that make interrogating the EMR for clinical trial recruitment challenging.
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry dedicated to delivering actionable insights. Learn more at www.iqvia.com.
